Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

The Antarctic Sabbatical , as the travel company is dubbing it, will give five people the opportunity to study how widely micro plastics have infiltrated the region. Over a month’s time in December, they’ll be trained in lab work in Chile, collect snow samples in Antarctica, climb key glaciers and even visit the South Pole. Scientist Kirstie Jones-Williams, who will be helping to train and guide the volunteer researchers, says the goal of the program isn’t to create more scientists, but moreso global ambassadors on the dangers of pollution and more. “The science itself that we’re doing isn’t enough,” she told The Associated Press in a recent interview. “Actually, one of the biggest threats to our sort of natural environment isn’t necessarily the lack of information that we have ... but it’s more the disenfranchisement that can occur with policymakers and apathy and eco-fatigue. “One of the main things is to get a bunch of people that can take the messages that we learn back to their respective countries,” she said. It’s the second offering in Airbnb’s sabbatical program, which offers its users a chance to take time to do more than see the sights but actually do some good. Earlier this year, Airbnb selected five people to spend three months in Grottole in southern Italy to help preserve the way of life in the town, which is in danger of disappearing. Airbnb’s Chris Lehane says both sabbaticals are part of the company’s larger goal of more eco-friendly travel and to raise awareness of tourism’s global footprint. “Airbnb is not going to solve climate change, but we all have a responsibility to do what we can and use our capacity to help take steps forward,” said Lehane, senior vice president of global policy and communications. “A lot of travel in the world takes place in and around big events,” he said. “Can we find ways when people are going to travel around these big events, to make them much more sustainable?” No scientific background is required to be selected for the Antarctic trip: However, a love of the environment and the ability to complete some of the physical tasks, such as collecting samples, climbing glaciers and enduring bitter cold, is paramount. “It is hard to work in cold environments so people that ... perhaps work well under pressure, work well when they’re tired, that’s actually quite key,” Jones-Williams said,” and to actually ask questions, and people that are really hungry to get as much as they can out of this experience. “It’s really people that kind of respect the scientific process,” she added. The five will stay in Airbnb’s in Chile for their training for about two weeks and will stay at a camp provided by Antarctic Logistics & Expeditions in Antarctica for about a week or so. Airbnb will partner with Ocean Conservancy to use the research for advocacy. Nick Mallos, a conservation biologist and ocean debris specialist for Ocean Conservancy, called it an “incredible opportunity,” and noted that the group has long worked with “citizen science volunteers” to help clean up the environment. “We’ve seen the power of when you train and empower individuals to perform science, they can generate invaluable information and data that ultimately then can form solutions,” he said. ___ Online: http://airbnb.com/sabbatical
Airbnb to train volunteers for science research sabbatical.

The story makes clear the “big unknown” remains the price and “how much people are willing to spend to cut a day or so off of a bout of flu.” The story reports that Genentech, the drug’s manufacturer, said it’s too early to comment on the drug’s U.S. price. The story also notes that in Japan, where the drug was invented, it “sells for the equivalent of about $43.50.” The story uses terms like “a little more than a day” and “nearly a day” and “substantially” to describe the drug’s reduction in flu symptoms, fever, and coughing and sneezing, respectively. It does not explain, as the news release does, that: “Similar efficacy results were seen between baloxavir marboxil and [Tamiflu] in relation to duration of symptoms and fever reduction.” In other words, on the symptom front, both drugs were the same. According to the news release, a difference was seen in the length of time the virus was shed from the body (presumably through coughing and sneezing): 24 hours for baloxavir marboxil verses 72 hours for Tamiflu. The news release also states that there was also a difference seen in the level of virus in the nose and throat, but it provides no precise numbers. It is not known whether this benefit translates into less infection transmission, and the story should have made that clear. The news release issued by Genentech about the FDA’s decision to grant priority review describes baloxavir marboxil’s most common side effects: diarrhea, bronchitis, nausea and sinusitis. The news release also states that overall incidence of adverse events seen in patients taking baloxavir marboxil were lower than those seen in both the placebo group and the group taking Tamiflu. The STAT News story does not mention any potential harms. This evidence comes from the randomized phase III Capstone-1 study the FDA will review, which included 1,436 people in the US and Japan. It excluded people older than 64. The news story does not note this exclusion, nor does it state a key problem with this study: It has never been published in a peer-reviewed journal (instead, a study abstract was released as part of ID Week 2017). This means the full data analysis has never been seen by anyone other than the researchers. We explained why this is important in February 2018, when we discussed news coverage of the drug’s approval in Japan. The 2017-2018 flu season was the worst the US had experienced in nearly a decade. The flu impacted the entire country, and was responsible for 172 pediatric deaths. The news article did not use these or any other flu-related statistics to increase fear about the flu and, in turn, the need for this medication. The article includes two sources: Mark Eisner, Genentech’s VP of product development for immunology, infectious diseases and ophthalmology and Richard Webby, head of the World Health Organization’s influenza collaborating center at St. Jude Children’s Research Hospital in Memphis. Eisner’s affiliation with Genentech, the drug’s manufacturer, is clearly noted. Webby does not appear to have any conflicts of interest. The article would have been stronger if it had included a third source who commented on what–if anything–is known about whether reducing the duration of symptoms leads to reduced levels of transmission that result in fewer people contracting the flu and fewer deaths. The story explains that the only other drug approved to treat the flu is Tamiflu, which is not widely used. The writer explains that both drugs need to be taken within 48 hours of symptom onset and that baloxavir marboxil is a single one-time dose, while Tamiflu must be taken twice daily for five days. It is clear from the story that the FDA is expected to decide by the end of the year whether to approve this new flu medication. The story explains that it’s been more than 20 years since a new class of flu drug has been developed and marketed. (It is available in Japan.) The catalyst for the story was a news release issued by Genentech about the FDA granting priority review of baloxavir marboxil, but the story does not use direct quotes from the news release.
A flu drug — shown to reduce the duration of symptoms — could upend treatment in U.S.

In mid-November 2015, a photograph purportedly showing what resemble common ladybugs and Japanese beetles embedded on the roof of a dog’s mouth began circulating via Facebook: Most of the users who shared the above-displayed image on Facebook included a variation of the following message: SOMEBODY ASKED ME TO PASS THIS ALONG …. Japanese Beetles and Lady Bugs can attach to the roof of your dog’s mouth, and make him/HER become ill. Symptoms include excessive drooling. Check your dog’s mouth and remove any insects. While we haven’t been able to identify who the “Somebody” is in the above-quoted Facebook post, a message posted by the Hands & Paws group did provide some information about the image’s origin: This posted photograph is recent — posted by a vet tech and when I saw the photo started doing research – because I too thought there was no way the photo could be real. There is no photoshop — there is no hidden agenda. It’s just me. The Founder of a tiny little dog rescue in Florida finding the photo and the facts behind the photo amazing, astonishing and wanted to share the information with my fellow dog lovers. We reached out to Hands & Paws for more information about the image without results, but multiple incidents are on record of beetles embedding in dogs’ mouths, such as this one from November 2016: Frances Jiriks brought her pooch Bailey into Hoisington Veterinary Hospital after he refused to eat, she told KAKE. He was also foaming at the mouth and a bit lethargic, the dog owner said. When they arrived at the animal clinic, Dr. Lindsay Mitchell discovered between 30 and 40 lady beetles clinging to the roof of Bailey’s mouth. The beetles look nearly identical to ladybugs though they secrete a mucus which allows them to stick, as they did inside Bailey’s mouth. The bugs were successfully removed from the dog’s mouth, but Mitchell warned their presence could pose a variety of health risks to man’s best friend. [Video here] In 2008, Lindsey Derek published an article in the journal Toxicon about the subject: A six-year old mixed-breed dog presented with severe trauma to the oral mucosa suggestive of chemical burn. Sixteen Harmonia axyridis (Coccinellidae) were removed from the oral cavity, which revealed trauma consistent with chemical burn. The beetles had become embedded in mucosa covering the hard palate and required manual removal. A diagnosis of beetle induced chemical burn was warranted and consistent with the nature of the chemical constituents of H. axyridis hemolymph. That article also included a photograph of the beetles in the dog’s mouth, which closely resembled the image circulated in November 2015:

Show your work and conclude with the exact phrasing "Therefore, the final answer is [answer]." where [answer] is just the final number or expression that solves the problem.
user
A photograph shows insects embedded in a dog's mouth.

